Dec. 8, 2024 — Patients with acute myeloid leukemia who have lower education and income are less likely to receive a allogeneic hematopoietic stem cell transplant for acute myeloid, however, if they ...
That is the finding of an observational study reported at the American Society of Haematology (ASH) congress, which focused on allogeneic or donor HSCTs used as a potentially curative treatment for ...
PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...
“The collaboration is pivotal to the development and optimization of TCB008 as a therapy for acute myeloid leukemia and other blood cancers.” CareDx's AlloCell test, a sensitive solution for ...